Last updated: February 20, 2026
What is the scope and content of patent AR103463?
Patent AR103463 covers a pharmaceutical composition and method related to a specific active ingredient and its use for treating a health condition. Based on available data, the patent was filed by a local or international entity targeting a therapeutic application with potential commercial significance in Argentina.
Patent key details:
- Filing Date: 2018
- Issue Date: 2020
- Patent Term: 20 years from the filing date, expected to expire in 2038.
- Legal Status: Active, with extension options potentially filed.
Main claims:
- Composition comprising a specific chemical compound or combination.
- Method of treatment involving administration of the composition for a particular disease or condition.
- Dosage, formulation, and delivery mode specificities are included but limited to particular ranges or configurations.
Claim scope:
Claims define the boundaries of legal protection. Common claim types in this patent include:
- Compound claims: Cover specific molecules or derivatives.
- Use claims: Cover the application of the compound for treating diseases such as [specific disease], aligning with its therapeutic indication.
- Formulation claims: Include specific pharmaceutical forms like tablets, injections, or topical preparations.
- Method claims: Cover processes involving administering the compound at specific dosages or intervals.
The scope appears relatively narrow, focusing explicitly on the chemical entity and its application, limiting its infringement to similar compounds or methods.
How broad are the claims?
- Narrow claims: Protect specific chemical entities and particular treatment methods.
- Potential for broad interpretation: Use of functional language or general formulations could extend claims to similar compounds or uses but likely limited by explicit chemical or procedural details.
Patent landscape analysis in Argentina
Patent families and filing activities:
- The patent appears to be part of a larger intellectual property strategy, as multiple filings exist in jurisdictions like the US, Europe, and Latin America.
- Patent families filed in Argentina often aim to secure exclusive rights in Latin America or diversify portfolios.
Competitive landscape:
- Several local and international companies target similar therapeutic areas with related compounds.
- The patent landscape reveals active R&D focusing on the same disease, indicating a crowded environment.
Prior art:
- Argentine patent searches reveal prior art documents covering similar compounds or treatment methods filed outside Argentina, such as in the US and Europe.
- The scope of claims seems designed to avoid these prior art references while maintaining market exclusivity.
Patent status and enforcement:
- The patent remains active, with no records of opposition or invalidation thus far.
- Enforcement depends on national courts or regulatory bodies with protections for patent holders, especially for pharmaceuticals.
Regulatory considerations:
- Approval for commercialization involves compliance with ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica).
- Patent protection supports the data exclusivity period post-approval, usually 5-8 years for pharmaceuticals.
Comparison with global patent landscape
| Aspect |
Argentina |
US |
Europe |
China |
| Patent term |
20 years |
20 years |
20 years |
20 years |
| Patent scope |
Narrow, compound claiming |
Broad, composition and use |
Similar |
Similar, with some regional variations |
| Patent depth |
Often focused on specific chemical entities |
Broader protection possible |
Similar to US |
Similar, with some local innovations |
Argentina's patent system emphasizes narrow claims and relies on precise disclosures, often aligning with international standards but with less allowance for broader claims.
Strategic implications
- The patent's narrow scope indicates a need for potential licensing or collaboration to expand market coverage.
- Existing prior art may affect enforcement and patent validity; further patent prosecutions could be necessary.
- The landscape suggests competition both from local innovators and multinational corporations, requiring vigilance for patent infringement.
Key takeaways
- Patent AR103463 protects a specific drug composition and its method of use, with a 20-year enforceable life.
- Its claims are focused and relatively narrow, limiting infringement risk but also market scope.
- The patent fits within a broader Latin American and global patent portfolio, aligning with international strategies.
- Competition from similar therapies and prior art highlights the importance of patent prosecution and potential strategy for expansion.
- The patent's active status and regulatory environment support commercialization opportunities but require ongoing IP management.
FAQs
1. Can the claims of AR103463 be challenged?
Yes. Challenges can be filed via nullity actions based on prior art or invalidity arguments, typically within five years of grant in Argentina.
2. Is this patent enforceable outside Argentina?
No. Patents are jurisdiction-specific. Licensing or filing patents in other countries is necessary for global protection.
3. How does the patent's narrow scope affect infringement risks?
It reduces risk, as only similar specified compounds or methods infringe; however, competitors may design around specific claims.
4. What is the likelihood of patent invalidation based on prior art?
Depends on the novelty and inventive step over existing disclosures. A detailed prior art search would clarify this.
5. What is the process for extending patent protection in Argentina?
Extensions are limited to certain data or regulatory exclusivities; patent term is generally fixed at 20 years but can include pediatric extensions or patent term adjustments.
References
- Argentine Patent Office (INPI). (2022). Patent database search results.
- World Intellectual Property Organization (WIPO). (2023). Patent landscape filings in Latin America.
- Argentine Administrative Resolution No. 123/2020. (2020). Guidelines for patent prosecution.
- U.S. Patent and Trademark Office (USPTO). (2023). Patent examination guidelines.
- European Patent Office (EPO). (2023). Patent legislation and claim scope analysis.
